US Patent 9862767 Therapeutic methods using anti-CD200 antibodies
Patent 9862767 was granted and assigned to Alexion Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9862767 Therapeutic methods using anti-CD200 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
